Rapid testing for resistant bacteria during hospital stays
Part of Infections clinical trials.
This study looks at whether a rapid test can help doctors detect CPE bacteria (which are resistant to many antibiotics) sooner, and whether using infection control measures can stop these bacteria from spreading. It may help you get the right care and reduce the risk of infection while in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to have had a rectal swab test for CPE bacteria within the first 5 days of being admitted to the hospital.
- You either tested positive for CPE (and are now in isolation) or are being checked to see if the bacteria are gone.
- You may be eligible if you came from another hospital or care facility, or have been hospitalized within the last month.
- Or if you are in a high-risk unit, such as a transplant or cancer ward.
- You must not have any missing or unusable test samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a faster test to find CPE, a type of bacteria that is resistant to many antibiotics. If you test positive for CPE while in the hospital, your information may be used to help improve how we screen and manage this bacteria.
This study checks if a special test (Xpert Carba-R) can find a type of drug-resistant bacteria, called CRE, in fluid from the lungs and in rectal swabs. It might help doctors treat lower respiratory tract infections more effectively.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
This study tests whether getting antibiotic resistance test results faster (within 6 hours) helps doctors choose the right antibiotic sooner for ICU patients with bloodstream infections caused by certain bacteria. Faster, accurate treatment may lead to better outcomes.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study looks at how well a new antibiotic (cefiderocol) works against a tough type of Klebsiella pneumoniae bacteria that is resistant to many other antibiotics. It may help find better treatments for serious infections.
Hear when a new Carbapenemase-Producing Enterobacterales (CPE) Colonization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.